Zhejiang Medicine: Completed the repurchase of 1.43% of shares

Zhejiang Medicine announced that on August 11, 2025, the company completed its share repurchase, having repurchased a total of 13.7232 million shares through the centralized bidding method on the Shanghai Stock Exchange, accounting for 1.43% of the company's current total share capital. The highest repurchase price was RMB 16.09 per share, the lowest price was RMB 13.31 per share, and the average repurchase price was RMB 14.57 per share, with a total amount of funds used being RMB 200 million. The repurchased shares will be used for the subsequent implementation of the employee stock ownership plan or equity incentives